Year: 2019

OMAHA, Neb., Dec. 18, 2019 (GLOBE NEWSWIRE) — On December 18, 2019, America First Multifamily Investors, L.P.’s (NASDAQ: ATAX) (the “Partnership”) announced it has moved its Schedule K-1 information to a “new and improved” website.  The Partnership’s unitholder K-1 information is now available using the Tax Package Support website at www.taxpackagesupport.com/ATAX. The website previously used to access Partnership Schedule K-1 information is no longer available.The new website contains various features designed to enhance the user experience and make it easier for unitholders to access their Schedule K-1 information.  In addition, the new website is compatible with most web browsers and may also be accessed using mobile devices.Further information can be found on the “K-1 Information”...

MIN-117 study did not meet its primary (MADRS) and key secondary (HAM-A) endpointsMIN-117 was generally well-tolerated with a safety profile comparable to placeboCompany to host conference call at 5:00 p.m. today (dial-in information below)WALTHAM, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, announced today the Phase 2b trial of MIN-117 in adult patients suffering from moderate to severe major depressive disorder (MDD) and presenting with symptoms of anxious distress failed to meet its primary and key secondary endpoints.Neither dose of MIN-117 tested in this trial showed a statistically significant separation from placebo on the reduction in the symptoms of MDD...

NEWARK, N.Y., Dec. 18, 2019 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) has received a $4.9 million firm-fixed price delivery contract from the U.S. Government’s Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5390 batteries. Shipments are expected to commence and be completed in 2020.“Ultralife has been a long-standing supplier to the U.S. military, and our BA-5390 battery is recognized for its long life, unsurpassed safety record and reliability under the toughest conditions.  We are pleased that DLA has once again selected this proven battery for its near-term power needs,” said Michael D. Popielec, President and Chief Executive Officer.About Ultralife CorporationUltralife Corporation serves its markets with products and services ranging from power solutions...

BIRMINGHAM, AL, Dec. 18, 2019 (GLOBE NEWSWIRE) — First US Bancshares, Inc. (Nasdaq: FUSB) (the “Company”), the parent company of First US Bank, announced today that the Company’s Board of Directors has extended the Company’s existing share repurchase program.  The repurchase program, which was originally approved by the Company’s Board of Directors on January 19, 2006, has been extended to expire on the date on which the Company has repurchased all of the 93,565 shares that may still be repurchased under the repurchase program, or on December 31, 2020, whichever is earlier.  To date, the Company has repurchased approximately 549,220 shares of common stock under the repurchase program.  Share repurchases under the repurchase program may be made through open market and privately negotiated...

RED BANK, N.J., Dec. 18, 2019 (GLOBE NEWSWIRE) — OceanFirst Financial Corp. (NASDAQ:OCFC), the holding company for OceanFirst Bank, today announced that it will issue its earnings release for the quarter ended December 31, 2019 on Monday, January 27, 2020 after the market close. Management will then conduct a conference call at 11:00 a.m. Eastern Time, on Tuesday, January 28, 2020 to discuss highlights of the Company’s fourth quarter operating performance.The direct dial number for the call is 1-888-338-7143. For those unable to participate in the conference call, a replay will be available. To access the replay, dial 1-877-344-7529, Replay Conference Number 10137684 from one hour after the end of the call until April 28, 2020.The conference call will also be available (listen-only) via the Internet by accessing the Company’s...

VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (das „Unternehmen“ oder „EMN“) freut sich, die Ernennung von Martina Blahova zum Chief Financial Officer des Unternehmens mit Wirkung zum 1. Januar 2020 bekannt zu geben. Im Rahmen der langjährigen Nachfolgeplanung des Unternehmens wird Martina Blahova Pierre Massé ersetzen, der zum 31. Dezember 2019 in den Ruhestand tritt.  Herr Massé wird mit dem Unternehmen zusammenarbeiten, um einen nahtlosen Übergang zu unterstützen, und weiterhin zur Verfügung stehen, um während dieser Übergangsphase Beratung und Hilfestellung anzubieten. Marco Romero, President und CEO von EMN, sagte dazu:„Pierre Massé trat kurz nach der Gründung in das Unternehmen...

VANCOUVER, Colombie-Britannique, 18 déc. 2019 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX : EMN) (la « Société » ou « EMN »), a le plaisir d’annoncer la nomination de Mme Martina Blahova au poste de directrice financière de la société, à compter du 1er janvier 2020. Conformément au plan de succession de longue date de la Société, Mme Blahova remplacera M. Pierre Massé, qui prendra sa retraite le 31 décembre 2019.  M. Massé travaillera avec la Société pour assurer une transition sans faille et restera disponible pour fournir des conseils et du soutien pendant la phase de transition. M. Marco Romero, PDG d’EMN, a déclaré :« Pierre...

CORTLAND, Ohio, Dec. 18, 2019 (GLOBE NEWSWIRE) — Cortland Bancorp (NASDAQ: CLDB), the holding company for The Cortland Savings and Banking Company, today announced that its Board of Directors authorized a share repurchase program (the “Program”).  Under the terms of the Program, the Company is authorized to repurchase up to 200,000 shares of the Company’s common stock, or approximately 4.6% of its outstanding common shares.  The Program is effective for calendar year 2020 and will commence on January 2, 2020. The Program follows the share repurchase program that expires on December 31, 2019. On a year-to-date basis through the close of business on December 16, 2019, the Company repurchased 54,000 shares of its common stock at an average price of $22.48 per share under the Company’s current stock...

REDWOOD CITY, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) — Rezolute, Inc. (“Rezolute” or “the Company”) (OTCQB:RZLT) today announced top-line results from its Phase 1 trial of AB101, an ultra-long acting basal insulin for potential use in patients with type 1 and type 2 diabetes. AB101 was administered subcutaneously in three ascending dosing cohorts in patients with type 1 diabetes, which resulted in slow onset and sustained insulin levels and activity for more than seven days. However, at the higher doses, the necessary drug volume was greater than anticipated, as was variability in onset time between patients. Consequently, the Company believes that additional formulation development is required before advancing the program further in the clinic.“Observing a slow, sustained release of insulin for...